Evaluating Dextrose-Derived Interference in Low-Concentration Monoclonal Antibody Quantification for Clinical In-Use Studies.
Saved in:
| Title: | Evaluating Dextrose-Derived Interference in Low-Concentration Monoclonal Antibody Quantification for Clinical In-Use Studies. |
|---|---|
| Authors: | Dachineni R; Drug Product Development, BioCMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania, 19380, USA., Naseer N; Analytical Development, BioCMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania, 19380, USA., Myers M; Analytical Development, BioCMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania, 19380, USA., Maijorovaite Z; Drug Product Development, BioCMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania, 19380, USA., Nie H; Drug Product Development, BioCMC, Teva Branded Pharmaceutical Products R&D LLC, West Chester, Pennsylvania, 19380, USA. haichen.nie01@tevapharm.com. |
| Source: | AAPS PharmSciTech [AAPS PharmSciTech] 2026 Mar 06; Vol. 27 (3). Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932 (Electronic) Linking ISSN: 15309932 NLM ISO Abbreviation: AAPS PharmSciTech Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1530-9932 |
|---|---|
| DOI: | 10.1208/s12249-026-03364-z |
